|21.72|| 0.00 / 0.00%|
Services to the Health Industry
Albany Molecular Research, Inc. is a research and manufacturing organization, which provides drug discovery, development, and manufacturing services. It operates through three segments: Discovery and Development Services, Active Pharmaceutical Ingredients (API), Drug Product and Fine Chemical. The Discovery and Development Services segment provides comprehensive services from hit identification to investigational new drug, including drug lead discovery, library design and synthesis, synthetic and medicinal chemistry, in vitro biology and pharmacology, lead optimization, chemical development, drug metabolism and pharmacokinetics and small-scale commercial manufacturing. The Active Pharmaceutical Ingredients segment includes pilot to commercial scale manufacturing of API, including intermediates and high potency and controlled substance manufacturing. The Drug Product segment consists of formulation through commercial scale production of complex liquid-filled and lyophilized parenteral formulations. The Fine Chemical segment provides lab to commercial scale synthesis of reagents and diverse compounds to the pharmaceutical, agrochemical, detergent and cosmetics industries. The company was founded by Thomas E. D'Ambra on June 20, 1991 and is headquartered in Albany, NY.
|William S. Marth||President, Chief Executive Officer & Director|
|George Svokos||Chief Operating Officer|
|Felicia Ladin||Chief Financial Officer, Treasurer & Senior VP|
|Jimmy Z. Wang||Chief Information Officer & Senior Vice President|
|Steven R. Hagen||Senior Vice President-Quality & Compliance|